2m 2m 2m 2m 2m 2m 2m
IMMIX BIOPHARMA (IMMX)
NASDAQ
$10.78+$0.26 (+2.42%)
Price as of Jul 14, 2026 5:07 AM EDT- $748.9MMarket Cap
- 264.01%1-Year Change
- BiotechnologyIndustry
IMMIX BIOPHARMA (IMMX)
$10.78+$0.26 (+2.42%)
IMMX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $10.52 | ||
Change | -$0.59 (-5.31%) | ||
Open | $11.19 | ||
High | $11.19 | ||
Low | $10.36 | ||
Previous Close | $11.11 | ||
Volume | 1,250,316 | ||
30-Day Average Volume | 2,477,794 | ||
1-Week Change | 0.67% | ||
1-Month Change | 24.50% | ||
1-Year Change | 264.01% | ||
3-Year Change | 351.50% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 71.2M | ||
Total Assets | $95.8M | ||
Market Cap | $748.9M | ||
Enterprise Value | $669.7M | ||
Period: QTR TTM FY | |||
Revenue | $20.0M | ||
Net Income | -$10.1M | ||
Free Cash Flow | -$9.9M | ||
EBIT | -$10.1M | ||
EBITDA | -$10.0M | ||
Net Working Capital | $81.7M | ||
EPS | -$0.18 | ||
Enterprise Value/EBITDA | -67 | ||
Enterprise Value/Revenue | 33 | ||
P/B | 9 | ||
P/E | -58 | ||
PEG | -2 | ||
Price/Free Cash Flow | -76 | ||
Price/Operating Cash Flow | -76 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | N/A | ||
Last Split Date | N/A | ||
Earnings & Revenue